FIRMANI LORI (Interim CFO) sold 36.0% of their position (261.00 shares) of DAMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2025ACC: 0000950170-25-002813
Officer· Interim CFO
Since Aug 2024
+4.74K
Net shares
Net buyer
$1.5K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
5.73K acquired · 987.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+726.00
Price / share
—
Trade value
—
% of position
New position
1/3/2025
0.00→726.00
Common Stock
Direct
Shares
−261.00
Price / share
$5.63
Trade value
$1.47K
% of position
36.0%
1/3/2025
726.00→465.00
Total
Net shares
+465.00
Net value
-$1.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2025 | M · Option Exercise | +726.00 | — | — | New position | 0.00 | 726.00 |
| Common Stock Direct | 1/3/2025 | S · Sale | −261.00 | $5.63 | $1.47K | 36.0% | 726.00 | 465.00 |
| Total | +465.00 | -$1.47K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
726.00 shares
Shares
−726.00
Strike price
Held after
1.47K
Exercisable
—
1/3/2025
Stock Option (right to buy)
Direct
Converts to
Common Stock
5K shares
Shares
+5K
Strike price
5.7
Held after
5K
Exercisable
—
1/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock726.00 shares | 1/3/2025 | M · Option Exercise | −726.00 | — | 1.47K | |
| Stock Option (right to buy) Direct | Common Stock5K shares | 1/3/2025 | A · Award | +5K | 5.7 | — | 5K |